- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Swissray takes steps to avoid stock delisting
Swissray takes steps to avoid stock delistingDigital x-ray developer Swissray International of New York City will propose a reverse stock split at a shareholder meeting in late August. The split would bring the company into compliance with
Swissray takes steps to avoid stock delisting
Digital x-ray developer Swissray International of New York City will propose a reverse stock split at a shareholder meeting in late August. The split would bring the company into compliance with listing requirements on the NASDAQ stock exchange, according to documents Swissray filed with the Securities and Exchange Commission.
Swissray must maintain a minimum closing bid price of at least $1 a share to remain listed on the NASDAQ, but the company's stock price has been trading below that level for the last several months. NASDAQ gave the company until Aug. 6 to meet the minimum bid requirements, but the company's stock did not rise above $1 by the deadline and was trading at 41 in mid-August.
The reverse stock split would enable Swissray's stock to trade above the NASDAQ minimum bid requirements, according to the SEC documents. Swissray is pondering a split at a minimum ratio of 1-for-4 and a maximum ratio of 1-for-10. The split was scheduled to be proposed at a special shareholders meeting on Aug. 31 in New York City.
- Search again
- Homepage
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
